Registry of Lobbyists

Monthly Communication Report

371-525014

Organization: Innovative Medicines Canada/Médicaments novateurs Canada
Associated registration: 782797-371-93
Communication date: 2022-02-10
Posted date: 2022-03-11

Designated Public Office Holders who participated in the communication: Jessica  Fullerton , Policy Advisor
Office of the Minister of Intergovernmental Affairs, Infrastructure and Communities, Infrastructure Canada (INFC) Footnote1
 
Subject Matter of the communication: Health,  Science and Technology,  Industry
 
Responsible Officer who filed this communication report: Pamela Fralick
 
As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication.

The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed.
 
 
  1. Footnote1  Indicates new information that was added through a monthly communications return.
 

Date Modified: